Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Pestronk

Showing results (71-80 of 151) with videos related to

Pageof 16
Sort By:
Science (New York, N.Y.)|February 17, 1984
Susceptibility of skeletal muscle to Coxsackie A2 virus infection: effects of botulinum toxin and denervationC G Andrew, D B Drachman, A Pestronk, et al.
Muscle & Nerve|January 1, 1989
Silver cholinesterase immunocytochemistry: a new neuromuscular junction stainK Alderson, A Pestronk, W C Yee, et al.
Muscle & Nerve|October 15, 1998
Primary alpha-sarcoglycan deficiency responsive to immunosuppression over three yearsA M Connolly, A Pestronk, S Mehta, et al.
Annals of the New York Academy of Sciences|January 1, 1987
Humoral pathogenesis of myasthenia gravisD B Drachman, S de Silva, D Ramsay, et al.
Clinical Immunology and Immunopathology|February 1, 1985
Treatment of experimental myasthenia gravis with cyclosporin AD B Drachman, R N Adams, K McIntosh, et al.
Neurology|May 11, 2005
Anti-sulfatide antibodies in HIV-infected individuals with sensory neuropathyG Lopate, A Pestronk, S Evans, et al.
Science (New York, N.Y.)|October 24, 1975
Myasthenia gravis: passive transfer from man to mouseK V Toyka, D B Brachman, A Pestronk, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 18, 2002
Myopathy with antibodies to the signal recognition particle: clinical and pathological featuresT Miller, M T Al-Lozi, G Lopate, et al.
Neurology|May 1, 1997
A beneficial effect of oxandrolone in the treatment of Duchenne muscular dystrophy: a pilot studyG Fenichel, A Pestronk, J Florence, et al.
Annals of Neurology|January 1, 1995
Myopathy and paraproteinemia with serum IgM binding to a high-molecular-weight muscle fiber surface proteinM T al-Lozi, A Pestronk, W C Yee, et al.
Pageof 16

Showing results (71-80 of 151) with videos related to

Sort By:
Pageof 16
Science (New York, N.Y.)|February 17, 1984
Susceptibility of skeletal muscle to Coxsackie A2 virus infection: effects of botulinum toxin and denervationC G Andrew, D B Drachman, A Pestronk, et al.
Muscle & Nerve|January 1, 1989
Silver cholinesterase immunocytochemistry: a new neuromuscular junction stainK Alderson, A Pestronk, W C Yee, et al.
Muscle & Nerve|October 15, 1998
Primary alpha-sarcoglycan deficiency responsive to immunosuppression over three yearsA M Connolly, A Pestronk, S Mehta, et al.
Annals of the New York Academy of Sciences|January 1, 1987
Humoral pathogenesis of myasthenia gravisD B Drachman, S de Silva, D Ramsay, et al.
Clinical Immunology and Immunopathology|February 1, 1985
Treatment of experimental myasthenia gravis with cyclosporin AD B Drachman, R N Adams, K McIntosh, et al.
Neurology|May 11, 2005
Anti-sulfatide antibodies in HIV-infected individuals with sensory neuropathyG Lopate, A Pestronk, S Evans, et al.
Science (New York, N.Y.)|October 24, 1975
Myasthenia gravis: passive transfer from man to mouseK V Toyka, D B Brachman, A Pestronk, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 18, 2002
Myopathy with antibodies to the signal recognition particle: clinical and pathological featuresT Miller, M T Al-Lozi, G Lopate, et al.
Neurology|May 1, 1997
A beneficial effect of oxandrolone in the treatment of Duchenne muscular dystrophy: a pilot studyG Fenichel, A Pestronk, J Florence, et al.
Annals of Neurology|January 1, 1995
Myopathy and paraproteinemia with serum IgM binding to a high-molecular-weight muscle fiber surface proteinM T al-Lozi, A Pestronk, W C Yee, et al.
Pageof 16